Member Info for FootieladBaz

But Condao, when Darwin converts their shares lthey are NEW shares issued by the company at a percentage lower than the last five days average price. This 12 million purchase is for shares already in the market at a price much higher than the average last five days.

With apologies to experienced investors, here is some information for you just so that you know what I was referring to. An RNS is the regulatory news service, which requires reporting to the stock exchange by any company when something significant or relevant to shareholders or the market happens. This would include anyone filing a TR1 form with the company. A TR1 form must be legally filed by anyone who buys or sells shares if they own over 3% of the company. This is in tranches of 1%. In other words, each 1% change requires a new form to be filed. Anyone hitting 30% of ownership has to automatically make a bid for the company. Whether this purchase of 12 million shares was by someone who already owns shares or not, it will still require a filing of form TR1 based on the amount. As such, that will trigger an RNS. I hope that is all clear. Best wishes, Baz

12,000,000 purchased on Friday. Let's wait to see the RNS this week to see who on the TR1.

Am I the only investor to think the RNS wasn't too bad? I've read every word very carefully and in my opinion, I really don't think we're in a worse position than before we were suspended this time last year when the share price was 17p.

AND China is having a big love-in with Kazakhstan. http://www.chinadaily.com.cn/bizchina/chinadata/2017-06/09/content_29686334.htm

Hi Earlstone - I feel your pain - honestly. An average of 32p still only provides a market cap of £42.88m. I won't express a view of the Board but I will comment on the products that are now coming through. I do think that back in the day when you were invested at 32p, there was a lot of hope but no proof of products. You must have been convinced at the time. Now we are financed (albeit by Darwin whatever you think of them) but with a pipeline of products in different markets and new ones being worked on (eg water). If this company works out...and I say if...then even a market cap of £42m could seem pretty cheap. ASOS bought me a house, I hope GRPH can buy me another one. Oh if I had a crystal ball!

Not sure why you think it saves tax as (1) we're bang in the middle of the tax year (2) there's no VAT on the payment and (3) we're carrying forward £30m of losses anyway so nowhere near paying Corp Tax. All in all I think we're moving forward as we should be and as usual the MMs are just bored, hence we have the usual share price drift in quieter periods. I for one will be topping up again in the next few weeks. All the best, Baz

Now we know the recent share trades showing on this site as sells are definitely false as my purchase of 110,343 shares at 10.59 is showing as a sell when it is DEFINITELY a buy.

Indeed. Which is why I just purchased £5k and got a price of only 4.52p. That suggests to me that some of those earlier smaller 'sales' could also be buys.

A successful pilot in another division of the company. Now we have even more potential pipelines for future success.

All fair points...I do believe the Darwin injection of funds (albeit causing dilution) does tide the company over towards achieving more successful sales of products now proven. For transparency I can declare a good five figure sum invested here and for me this is a medium to long term hold. This is one of those shares that will either just drift or x100...I believe elements are in place to suggest the latter!

No stopping us now with the good news RNS about financing. Four additional banks in the syndicate to support us...huge amount of new funds available at the same rate as before...significantly extended period to pay back...growth of our production assured. Excellent as a long term hold for me.

that's just China's contribution. The whole project includes 30 countries. Total $900 billion

Agree 100% with that.

TD is showing down 1.5%. I can live with that or a bit more. Darwin is back in for Tranche 2, yes. But did you note in the RNS, that debt restructuring will be completed by the end of June so look forward to that RNS early July. Also reference to water as well as polymer in the RNS as well. as I've been saying since we were out of suspension, don't panic, let's get the debt consolidated, be refinanced, refocused, and move forward successfully. We need to wait a little more. In the meantime, I will be putting my money where my mouth is.

ooo passive aggressive Jumbo. let's wait and see eh?

Trump may be stalling regarding his massive infrastructure plans which we know would boost us. However, President Xi of China is pressing ahead with a similar sized project from China through the Silk Road going west. This will definitely help us! https://www.theguardian.com/world/2017/may/14/china-xi-silk-road-vision-belt-and-road-claims-empire-building?utm_source=esp&utm_medium=Email&utm_campaign=GU+Today+main+NEW+H+categories&utm_term=225926&subid=10352905&CMP=EMCNEWEML6619I2

Actually I am still well invested and will buy more in a few weeks. I realise this is a risk but it's this kind of share that gives me a risk/reward I can bear. Darwin is out and restructuring is happening. Two key products have been tested and are finally out there in the market so we'll see what can be made long term. I'll either lose a lot or perhaps my 100k could turn into 5mill. None of you can answer for sure so no abuse please. let's hope the rest of us in here see things turn around significantly long term. All the best, Baz.

Well I just had a look at Sanofi's valuation...112 Billion Euros. I wouldn't be upset if they bought us for just 2% of that value....

...in the Annual Report: "The Company believes its existing cash and cash equivalents, including an anticipated $22.0 million payment for a near-term development milestone under the licence and collaboration agreement with Sarepta, will be sufficient to enable it to fund its operating expenses and capital expenditure requirements through 31 December 2018.